NCT06276933 2024-02-26
A Study of Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Tongji University
Phase 4 Not yet recruiting
Clinical Trials
4 trialsNCT03666728 2021-03-17
A Study of SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLC
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Terminated
NCT04425135 2020-06-11
Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy (Pemetrixed + Carboplatin) in Patients With Tyrosine Kinase Inhibitor Failure in ALK-positive Advanced NSCLC
The First Affiliated Hospital of Xiamen University
Phase 2 Unknown
NCT04108013 2019-09-27
A Study of SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC
Xuanwu Hospital, Beijing
Phase 2 Unknown